The dose of Sonata should be individualized. The recommended dose of Sonata for most nonelderly adults is 10 mg. For certain low weight individuals, 5 mg may be a sufficient dose. This dosage modification is necessary if a patient has any problems like liver or kidney impairment. Sonata® is a registered trademark of King Pharmaceuticals Research and Development, Inc. Zaleplon may be habit-forming. Keep the medication in a place where others cannot get to it. Misuse of Sonata can cause addiction or overdose like conditions, especially in a child or other person using the medicine without a prescription.
Sonata is indicated for the short-term treatment of insomnia as it belongs to the class of Sedative and hypnotics. It decreases the time to the onset of sleep and was used for up to 5-weeks in clinical trials. It does not increase total sleep time or decrease the number of awakenings.
This medication should not be prescribed to patients with hypersensitivity, amnesia, patient with hepatic impairment, or having any respiratory diseases. Therapy can cause drowsiness and a decreased level of consciousness; patients, particularly the elderly, are at higher risk of falls. An overdose of zaleplon can be fatal, especially when it is taken together with other medications that can cause drowsiness.